Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CAPTNASDAQ:CYTRNASDAQ:FGMNASDAQ:FPA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPTCaptivision$1.13-0.9%$0.80$0.37▼$3.11$34.59M1.071.62 million shs254,200 shsCYTRLadRx$0.09$0.05▼$0.86$4.14MN/A99,706 shs4,000 shsFGMFirst Trust Germany AlphaDEX Fund$55.93-0.8%$53.29$35.02▼$56.47$61.52M1.0211,980 shs6,417 shsFPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund$35.84+0.3%$32.41$24.19▼$38.66$19.71M0.973,549 shs9,391 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPTCaptivision0.00%0.00%+5.56%+128.00%-57.30%CYTRLadRx0.00%0.00%0.00%0.00%0.00%FGMFirst Trust Germany AlphaDEX Fund+0.46%+3.85%+3.11%+21.54%+52.77%FPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund+2.35%+0.45%+12.18%+23.55%+27.61%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCAPTCaptivisionN/AN/AN/AN/AN/AN/AN/AN/ACYTRLadRxN/AN/AN/AN/AN/AN/AN/AN/AFGMFirst Trust Germany AlphaDEX FundN/AN/AN/AN/AN/AN/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAPTCaptivision 0.00N/AN/AN/ACYTRLadRx 0.00N/AN/AN/AFGMFirst Trust Germany AlphaDEX Fund 0.00N/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAPTCaptivision$14.64M2.36N/AN/A($1.61) per share-0.70CYTRLadRxN/AN/AN/AN/AN/AN/AFGMFirst Trust Germany AlphaDEX FundN/AN/AN/AN/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAPTCaptivision-$74.73MN/A0.00∞N/AN/AN/AN/AN/ACYTRLadRxN/AN/A0.00N/AN/AN/AN/AN/AN/AFGMFirst Trust Germany AlphaDEX FundN/AN/A13.97∞N/AN/AN/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/AN/A10.39∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCAPTCaptivisionN/AN/AN/AN/AN/ACYTRLadRxN/AN/AN/AN/AN/AFGMFirst Trust Germany AlphaDEX Fund$0.410.73%N/AN/AN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund$1.032.87%N/AN/AN/ALatest CYTR, FGM, FPA, and CAPT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/25/2025FGMFirst Trust Germany AlphaDEX FundQuarterly$0.37502.7%6/26/20256/26/20256/30/20256/25/2025FPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundQuarterly$0.33503.73%6/26/20256/26/20256/30/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAPTCaptivisionN/ACYTRLadRxN/AFGMFirst Trust Germany AlphaDEX FundN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/AInsider OwnershipCompanyInsider OwnershipCAPTCaptivision0.41%CYTRLadRxN/AFGMFirst Trust Germany AlphaDEX FundN/AFPAFirst Trust Asia Pacific ex-Japan AlphaDEX FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCAPTCaptivisionN/A30.61 million30.49 millionOptionableCYTRLadRxN/A45.04 millionN/ANot OptionableFGMFirst Trust Germany AlphaDEX Fund147,0001.10 millionN/ANot OptionableFPAFirst Trust Asia Pacific ex-Japan AlphaDEX Fund147,000550,002N/ANot OptionableCYTR, FGM, FPA, and CAPT HeadlinesRecent News About These CompaniesLongleaf Partners Asia Pacific UCITS Fund Q1 2022 CommentaryJune 4, 2022 | seekingalpha.comInstitutional Investor Publishes 2022 Asia Pacific (ex-Japan) Research Rankings, Including Local Regional ResultsMay 30, 2022 | yahoo.comFirst Trust Asia Pacific ex-Japan AlphaDEX Fund declares quarterly distribution of $0.3515March 25, 2022 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCYTR, FGM, FPA, and CAPT Company DescriptionsCaptivision NASDAQ:CAPT$1.13 -0.01 (-0.88%) Closing price 04:00 PM EasternExtended Trading$1.13 0.00 (0.00%) As of 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Captivision Inc. engages in the development and manufacture of an architectural media glass product called G-Glass which is an IT-enabled construction material capable of transforming buildings into digital media devices. The company was founded on February 24, 2023 and is headquartered in Nailsworth, the United Kingdom.LadRx NASDAQ:CYTRLadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.First Trust Germany AlphaDEX Fund NASDAQ:FGM$55.93 -0.43 (-0.76%) As of 03:13 PM EasternThe First Trust Germany AlphaDEX Fund (FGM) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Germany index. The fund tracks a tiered equal-weighted index of 40 companies selected from the S&P Germany BMI based on the S&P's AlphaDex selection methodology. FGM was launched on Feb 14, 2012 and is managed by First Trust.First Trust Asia Pacific ex-Japan AlphaDEX Fund NASDAQ:FPA$35.84 +0.11 (+0.31%) As of 03:59 PM EasternThe First Trust Asia Pacific Ex-Japan AlphaDEX Fund (FPA) is an exchange-traded fund that mostly invests in total market equity. The fund selects and weights 100 stocks from the S&P Asia Pacific Ex-Japan BMI Index based on their growth and value factors. FPA was launched on Apr 18, 2011 and is managed by First Trust. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
